Skip to content

ADVANCING
CURES

Accelerating discovery and development of new products addressing unmet clinical need.

VIC supports rapid-pace, high-impact research initiatives that are in the process of safely transitioning from the research lab to patients

VIC supports rapid-pace, high-impact research initiatives

VIC aims to advance research initiatives efficiently from discovery through the preclinical stage to early clinical testing to enable successful product development by an industry or a non-profit partner.

Clinical
Discovery

0

Labs working together with one initiative. 

0

best in class collaborators and Partners

0
novel medical products under development

VIC PROGRAMS ARE FUNDED BY GRANTS FROM US GOVERNMENT AGENCIES, PRIVATE FOUNDATIONS, CONTRACTS FROM BIOTECHNOLOGY COMPANIES AND PHILANTHROPISTS.

VIC pivots to address COVID-19 pandemic

We face a time of great uncertainty as a result of the Coronavirus or COVID-19 Pandemic that comes along with unprecedented events of every type, physical, social and economic.

VIC finds itself at the epicenter of this battle against an entirely new foe while being at the forefront of rapid vaccine development for emerging infectious diseases. The VIC team has worked very hard with the US Government and Biotechnology Companies and we have put in place a plan to turn our rapid vaccine development platform, VaxCelerate, towards the development of a safe and effective self-assembling vaccine for COVID-19 and, on a separate front, for the rapid development of a new blood test for the virus.

To begin to turn this wheel we need start-up support in the amount of $500K. Our donors have been amazingly generous over the past 11 years making VIC what is today with 9 new medical products under development, three first in human studies and 3 biotech company spinouts.

Collectively, with your help, we are now in the right place and at the right time to join the battle against the Coronavirus and you should know that your contributions will go directly towards VIC’s mission to assist in the global cause.

Thank you for your support,
Mark C. Poznansky MD, PhD